
Kerafast, Inc.: A leading reagent firm providing laboratory research tools including cell lines, antibodies, and more.
Kerafast, Inc. was founded with the core mission of accelerating scientific research by providing unique and high-quality laboratory reagents directly from leading laboratories worldwide. The company's vision is to facilitate global scientific collaboration and innovation by making rare and valuable research tools easily accessible. Kerafast offers a wide range of products including cell lines, antibodies, small molecules, dyes, and other essential reagents. Their market focus spans various research areas such as cancer research, cardiovascular studies, cell biology, drug discovery, and immunology.
Notable affiliated individuals include leading scientists and researchers who contribute their unique reagents to Kerafast's catalog. The company has secured investments from prominent venture capital firms in the biotech sector. Key achievements include the establishment of a comprehensive online platform that connects researchers with hard-to-find reagents, significantly speeding up the research process. Kerafast's overall impact lies in its ability to democratize access to specialized research tools, thereby fostering innovation and collaboration in the scientific community.
Companies similar to Kerafast include Caisson Laboratories, Cayman Chemical Company, Scientist.com and Zymo Research.
Kerafast was founded in 2010.
Kerafast's headquarters is located in Boston, MA, US.
Kerafast's most recent funding round was for $100k (USD) in February 2016.
As of Feb 26, 2016, Kerafast has disclosed funding of $3.9M (USD). Undisclosed round amounts are excluded.
Kerafast has 30 employees as of Feb 5, 2024.
Zymo Research
zymoresearch.com